(Verbatim from the application): While nitric oxide (NO) is believed to contribute to cardiac allograft rejection, me precise mechanism is not understood. We will examine the intracellular molecular mechanisms for the actions of excess NO on cardiac allograft contractile dyskinesis relating to a paradigm which includes both oxidative and nitrosative stress. We will examine the regulation of inducible NO synthase (iNOS) gene expression by the oxidant-sensitive NF-kB transcription factor and examine key candidate cytosolic and mitochondrial proteins as molecular targets of NO. These proteins include myoglobin and aconitase. In vitro nitrosylation of these proteins are known to inhibit enzyme activity and 02 binding, thus, interfering with efficient 02 utilization by this O2-demanding organ. Hypothesis: [NO derived from iNOS targets certain cellular proteins for nitrosylation within cardiac grafts that contribute to myocardial contractile dysfunction. Furthermore, reactive oxygen plays a role in regulating iNOS gene expression at the transcriptional level via activation of the oxidant-sensitive transcription factor (NF-KB).] The applicant will use advanced, state-of-the-art molecular and biophysical techniques including: transcription factor regulation of iNOS gene (gel shift assays; Northern and Western analysis); in situ sonomicrometry; measures of nitrosyl protein and function (EPR, electron paramagnetic resonance spectroscopy and immunoprecipitation); assay for apoptosis; quantitation of reactive oxygen (EPR spin trapping; salicylate trapping); evaluation with iNOS knockout and SOD1 or SOD2 transgenic mice. The applicant will show that following allogeneic cardiac transplantation:
Aim #1 : [Induction of iNOS leads to iron-nitrosyl complex formation within myocardium and contractile dysfunction during allogeneic cardiac transplantation.];
Aim #2 : [Certain candidate proteins are molecular targets of nitrosylation by excess NO in allogeneic transplantation.];
Aim #3 : [iNOS gene deletion prevents nitrosyiprotein formation and prolongs graft survival. ];
Aim #4 : [iNOS gene expression during allogeneic transplantation is regulated by activation of NF-KB.];
Aim #5 : [Antioxidants inhibit activation of NF-KB, induction of iNOS, formation of nitrosyl complexes and enhance contractile function.];
Aim #6 : [Antioxidant transgene overexpression inhibits activation of NF-kB, induction of iNOS, formation of nitrosyl complexes and enhances contractile function during allogeneic cardiac transplantion.] These studies will provide a novel mechanism to explain the pathogenesis of dyskinesis and graft failure during cardiac transplant rejection.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL064637-01A1
Application #
6258634
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Massicot-Fisher, Judith
Project Start
2001-07-01
Project End
2005-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
1
Fiscal Year
2001
Total Cost
$364,775
Indirect Cost
Name
Medical College of Wisconsin
Department
Surgery
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Nilakantan, Vani; Zhou, Xianghua; Hilton, Gail et al. (2006) Antagonizing reactive oxygen by treatment with a manganese (III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants. J Thorac Cardiovasc Surg 131:898-906
Nguyen, Thanh K; Nilakantan, Vani; Felix, Christopher C et al. (2006) Beneficial effect of alpha-tocopheryl succinate in rat cardiac transplants. J Heart Lung Transplant 25:707-15
Pieper, Galen M; Nilakantan, Vani; Halligan, Nadine L N et al. (2005) Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity. Biochem J 391:541-7
Nilakantan, Vani; Zhou, Xianghua; Hilton, Gail et al. (2005) Hierarchical change in antioxidant enzyme gene expression and activity in acute cardiac rejection: role of inducible nitric oxide synthase. Mol Cell Biochem 270:39-47
Pieper, Galen M; Nilakantan, Vani; Zhou, Xianghua et al. (2005) Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts. J Pharmacol Exp Ther 312:774-9
Pieper, Galen M; Nilakantan, Vani; Chen, Min et al. (2005) Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants. J Pharmacol Exp Ther 314:53-60
Nilakantan, Vani; Halligan, Nadine L N; Nguyen, Thanh K et al. (2005) Post-translational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase. J Heart Lung Transplant 24:1591-9
Khanna, Ashwani K; Plummer, Matthew S; Hilton, Gail et al. (2004) Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications. Circulation 110:3822-9
Pieper, Galen M; Khanna, Ashwani K; Kampalath, Bal N et al. (2004) Inhibition of nitrosylation, nitration, lymphocyte proliferation, and gene expression in acute and delayed cardiac allograft rejection by an orally active dithiocarbamate. J Cardiovasc Pharmacol 43:522-30
Pieper, Galen M; Nilakantan, Vani; Hilton, Gail et al. (2004) Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection. Am J Physiol Heart Circ Physiol 286:H525-34

Showing the most recent 10 out of 13 publications